Upendra Marathi

676 total citations
15 papers, 467 citations indexed

About

Upendra Marathi is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Upendra Marathi has authored 15 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Upendra Marathi's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Inflammatory mediators and NSAID effects (5 papers) and DNA Repair Mechanisms (4 papers). Upendra Marathi is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Inflammatory mediators and NSAID effects (5 papers) and DNA Repair Mechanisms (4 papers). Upendra Marathi collaborates with scholars based in United States and Sweden. Upendra Marathi's co-authors include Lenard M. Lichtenberger, Frank L. Lanza, Deepak L. Bhatt, Byron Cryer, Jing-fei Dong, Roger A. Kroes, Leonard C. Erickson, Dominick J. Angiolillo, Bhupinderjit S. Anand and Walter Jeske and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Upendra Marathi

15 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Upendra Marathi United States 10 157 151 144 105 47 15 467
Dermot Kearney Australia 6 146 0.9× 249 1.6× 53 0.4× 82 0.8× 19 0.4× 11 447
Emanuela Marcantoni Italy 10 89 0.6× 130 0.9× 99 0.7× 39 0.4× 93 2.0× 10 435
Rachel Sparks United States 9 54 0.3× 181 1.2× 183 1.3× 96 0.9× 57 1.2× 11 506
Kenneth Coggins United States 8 80 0.5× 164 1.1× 139 1.0× 43 0.4× 36 0.8× 10 496
Mu-Peng Li China 11 112 0.7× 35 0.2× 92 0.6× 47 0.4× 74 1.6× 27 332
H. J. Reimers Canada 12 160 1.0× 81 0.5× 81 0.6× 67 0.6× 14 0.3× 23 567
Janice Rischke Canada 11 149 0.9× 75 0.5× 48 0.3× 84 0.8× 22 0.5× 16 396
H. Narjes Germany 11 69 0.4× 158 1.0× 111 0.8× 66 0.6× 114 2.4× 17 461
Yvonne Pak United States 12 74 0.5× 43 0.3× 143 1.0× 59 0.6× 95 2.0× 17 534
Denis Delebassée France 7 281 1.8× 66 0.4× 42 0.3× 116 1.1× 17 0.4× 9 457

Countries citing papers authored by Upendra Marathi

Since Specialization
Citations

This map shows the geographic impact of Upendra Marathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Upendra Marathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Upendra Marathi more than expected).

Fields of papers citing papers by Upendra Marathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Upendra Marathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Upendra Marathi. The network helps show where Upendra Marathi may publish in the future.

Co-authorship network of co-authors of Upendra Marathi

This figure shows the co-authorship network connecting the top 25 collaborators of Upendra Marathi. A scholar is included among the top collaborators of Upendra Marathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Upendra Marathi. Upendra Marathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lewis, Lionel D., William Schary, Siddhartha De, et al.. (2022). 603 A randomized, placebo-controlled, first in human phase I single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy male volunteers of the immunostimulant 7HP349. Regular and Young Investigator Award Abstracts. A632–A632. 1 indexed citations
2.
Lokugamage, Nandadeva, Imran H. Chowdhury, Shen‐An Hwang, et al.. (2021). Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease. npj Vaccines. 6(1). 114–114. 9 indexed citations
3.
Angiolillo, Dominick J., Deepak L. Bhatt, Frank L. Lanza, et al.. (2020). Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation. Journal of Thrombosis and Thrombolysis. 49(3). 337–343. 13 indexed citations
4.
Angiolillo, Dominick J., Deepak L. Bhatt, Frank L. Lanza, et al.. (2019). Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study. Journal of Thrombosis and Thrombolysis. 48(4). 554–562. 28 indexed citations
5.
Hailemichael, Yared, et al.. (2019). Abstract 5010: Potentiating immune checkpoint blockade therapeutic efficacy using a small molecule activator of integrin cell adhesion receptors. Cancer Research. 79(13_Supplement). 5010–5010. 6 indexed citations
6.
Bhatt, Deepak L., Tilo Großer, Jing-fei Dong, et al.. (2017). Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus. Journal of the American College of Cardiology. 69(6). 603–612. 106 indexed citations
7.
Cryer, Byron, Deepak L. Bhatt, Frank L. Lanza, et al.. (2010). Low-Dose Aspirin-Induced Ulceration Is Attenuated by Aspirin–Phosphatidylcholine: A Randomized Clinical Trial. The American Journal of Gastroenterology. 106(2). 272–277. 70 indexed citations
8.
Cryer, Byron, Deepak L. Bhatt, Frank L. Lanza, et al.. (2010). T1143 Reduction of Gastroduodenal Ulceration With Aspirin-Phosphatidylcholine Complex Versus Aspirin—Potential Importance of Local Mucosal Injury. Gastroenterology. 138(5). S–497. 1 indexed citations
9.
Lichtenberger, Lenard M., et al.. (2009). Association of phosphatidylcholine and nsaids as a novel strategyto reduce gastrointestinal toxixity. Drugs of today. 45(12). 877–877. 54 indexed citations
10.
Lanza, Frank L., Upendra Marathi, Bhupinderjit S. Anand, & Lenard M. Lichtenberger. (2008). Clinical trial: comparison of ibuprofen‐phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients. Alimentary Pharmacology & Therapeutics. 28(4). 431–442. 52 indexed citations
11.
Marathi, Upendra, et al.. (1998). RAD1,a Human Structural Homolog of theSchizosaccharomyces pombe RAD1Cell Cycle Checkpoint Gene. Genomics. 54(2). 344–347. 20 indexed citations
12.
Marathi, Upendra, et al.. (1997). Retroviral transfer of a bacterial alkyltransferase gene (ada) into human bone marrow cells protects against O6-benzylguanine plus 1, 3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.. PubMed. 3(2). 301–7. 4 indexed citations
13.
Harris, Linda C., Upendra Marathi, Carol C. Edwards, et al.. (1995). Retroviral transfer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytotoxicity.. PubMed. 1(11). 1359–68. 26 indexed citations
14.
Marathi, Upendra, Roger A. Kroes, M. Eileen Dolan, & Leonard C. Erickson. (1993). Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.. PubMed. 53(18). 4281–6. 30 indexed citations
15.
Pieper, Russell O., et al.. (1991). Direct Correlation Between Methylation Status and Expression of the Human O-6-MethyIguanine DNA Methyltransferase Gene. PubMed. 3(8). 241–253. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dermot Kearney Breakdown of academic impact, for papers by Emanuela Marcantoni Breakdown of academic impact, for papers by Rachel Sparks Breakdown of academic impact, for papers by Kenneth Coggins Breakdown of academic impact, for papers by Mu-Peng Li Breakdown of academic impact, for papers by H. J. Reimers Breakdown of academic impact, for papers by Janice Rischke Breakdown of academic impact, for papers by H. Narjes Breakdown of academic impact, for papers by Yvonne Pak Breakdown of academic impact, for papers by Denis Delebassée
Rankless by CCL
2026